Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease
- 8 March 2025
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 60 (5) , 725-728
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health.
This publication has 12 references indexed in Scilit:
- Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantationScience Translational Medicine, 2024
- Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaHemaSphere, 2024
- Chronic graft-versus-host disease: unresolved complication or ancient history?Blood, 2024
- Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell TransplantationBlood, 2023
- Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National RegistryTransplantation and Cellular Therapy, 2023
- The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host diseaseBlood Advances, 2022
- Distinction of lymphoid and myeloid clonal hematopoiesisNature Medicine, 2021
- Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationLeukemia, 2021
- Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2019
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015